Effect of Filgotinib on Body Mass Index (BMI) and Effect of Baseline BMI on the Efficacy and Safety of Filgotinib in Rheumatoid Arthritis

INTRODUCTION: This post hoc analysis of the phase 3 rheumatoid arthritis (RA) filgotinib clinical trial program assessed the effect of filgotinib on body mass index (BMI) in patients with RA and the impact of BMI on the efficacy and safety of filgotinib. METHODS: FINCH 1–3 were randomized, double-bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Balsa, Alejandro, Wassenberg, Siegfried, Tanaka, Yoshiya, Tournadre, Anne, Orzechowski, Hans-Dieter, Rajendran, Vijay, Lendl, Udo, Stiers, Pieter-Jan, Watson, Chris, Caporali, Roberto, Galloway, James, Verschueren, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654312/
https://www.ncbi.nlm.nih.gov/pubmed/37747626
http://dx.doi.org/10.1007/s40744-023-00599-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654312/
https://www.ncbi.nlm.nih.gov/pubmed/37747626
http://dx.doi.org/10.1007/s40744-023-00599-1

Ejemplares similares